Ongoing study - The KCE has already published three reports on proton therapy. Since the last report in 2019, the scientific evidence base has been further developed and the results of several new studies on various types of tumours, including the first randomised controlled trials (RCTs), have been published. These new data provide an opportunity to gain a better understanding of the clinical indications in which proton therapy can offer significant benefits. At the same time, the Belgian reimbursement framework has changed.
These procedural changes, combined with the emergence of new clinical evidence, now make it necessary to reassess the current indications for proton therapy.
SEE ALSO
- Study 2018-15 (HSR) Shifting care from inpatient towards day-care and ambulatory care: impact on readmission rates & post-discharge mortality
- Study 2020-01 (HTA) Assessment of a mobile application in the rehabilitation of patients undergoing primary knee or hip arthroplasty
- Study 2023-06 (HSR) How to improve the access to supportive care for children with life-threatening or life-limiting diseases and their family?
- Study 2023-53 (HSR) Evaluation of the pilot project to implement the New Deal model.
- Study 2023-60 (collaboration): Clinical effectiveness and safety of immunisation against respiratory syncytial virus (RSV)
CONTACT
